Volume 11 Issue 2
Mar.  2020
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2020  >  11(2): 282-287
Ye Bogen, Zhang Lei. Interpretation of Guild to the Quality and Safety of Organs for Transplantation (6th edition): risk of infectious disease transmission[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 282-287. doi: 10.3969/j.issn.1674-7445.2020.02.016
Citation: Ye Bogen, Zhang Lei. Interpretation of Guild to the Quality and Safety of Organs for Transplantation (6th edition): risk of infectious disease transmission[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 282-287. doi: 10.3969/j.issn.1674-7445.2020.02.016
shu

Interpretation of Guild to the Quality and Safety of Organs for Transplantation (6th edition): risk of infectious disease transmission

doi: 10.3969/j.issn.1674-7445.2020.02.016

  • Department of Organ Transplantation, the First Affiliated Hospital of Navy Military Medical University, Shanghai 200433, China

More Information
  • Corresponding author: Zhang Lei, Email: zl3514@139.com
  • Received Date: 2019-11-01
    Available Online: 2021-01-19
  • Publish Date: 2020-03-15
    Abstract
  • Donor infection can be transmitted to the recipients through the grafts, leading to complications and even death. Donor-derived infection is an important cause of early infection after solid organ transplantation. The Chinese version of Guide to the Quality and Safety on Organs for Transplantation (6th edition) drafted by European Union in 2016 has been officially published. The Chapter 8 entitled 'Risk of infectious disease transmission' elaborates the medical history and behavioral history of infection risk of asymptomatic donors, basic screening highlights of various types of infections, transmission risk, prevention and control strategies of various pathogens. This chapter was mainly interpreted in this article.

     

    • FullText(HTML)
  • loading
    • References(31)
  • [1]
    中华医学会器官移植学分会, 中华预防医学会医院感染控制学分会, 复旦大学华山医院抗生素研究所.中国实体器官移植供者来源感染防控专家共识(2018版)[J].中华器官移植杂志, 2018, 39(1):41-52.DOI: 10.3760/cma.j.issn.0254-1785.2018.01.008.

    Branch of Organ Transplantation of Chinese Medical Association, Branch of Hospital Infection Control of Chinese Preventive Medicine Association, Antibiotics Institute of Huashan Hospital of Fudan University. Expert consensus on prevention and control of solid organ transplant donor source infection in China (2018 edition)[J]. Chin J Organ Transplant, 2018, 39(1):41-52. DOI: 10.3760/cma.j.issn.0254-1785.2018.01.008.
    [2]
    European Committee (Partial Agreement) on Organ Transplantation (CD-P-TO) EDQM.移植器官质量与安全指南(原书第6版)[M].张雷, 译.北京: 科学出版社, 2019.
    [3]
    THWAITES GE, DAY NP. Approach to fever in the returning traveler[J]. N Engl J Med, 2017, 376(6):548-560. DOI: 10.1056/NEJMra1508435.
    [4]
    ANNAMBHOTLA PD, GURBAXANI BM, KUEHNERT MJ, et al. A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased-risk organ donors[J]. Transpl Infect Dis, 2017, 19(2). DOI: 10.1111/tid.12676.
    [5]
    SURYAPRASAD A, BASAVARAJU SV, HOCEVAR SN, et al. Transmission of hepatitis C virus from organ donors despite nucleic acid test screening[J]. Am J Transplant, 2015, 15(7):1827-1835. DOI: 10.1111/ajt.13283.
    [6]
    FOSTER MA, WEIL LM, JIN S, et al. Transmission of hepatitis A virus through combined liver-small intestine-pancreas transplantation[J]. Emerg Infect Dis, 2017, 23(4):590-596. DOI: 10.3201/eid2304.161532.
    [7]
    GAMBATO M, PÉREZ-DEL-PULGAR S, HEDSKOG C, et al. Hepatitis C virus RNA persists in liver explants of most patients awaiting liver transplantation treated with an interferon-free regimen[J]. Gastroenterology, 2016, 151(4):633-636. DOI: 10.1053/j.gastro.2016.06.025.
    [8]
    LEVITSKY J, FORMICA RN, BLOOM RD, et al. The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation[J]. Am J Transplant, 2017, 17(11):2790-2802. DOI: 10.1111/ajt.14381.
    [9]
    GOLDBERG DS, ABT PL, BLUMBERG EA, et al. Trial of transplantation of HCV-infected kidneys into uninfected recipients[J]. N Engl J Med, 2017, 376(24):2394-2395. DOI: 10.1056/NEJMc1705221.
    [10]
    NOWAK KM, WITZKE O, SOTIROPOULOS GC, et al. Transplantation of renal allografs from organ donors reactive for HCV antibodies to HCV-negative recipients: safety and clinical outcome[J]. Kidney Int Rep, 2016, 2(1):53-59. DOI: 10.1016/j.ekir.2016.09.058.
    [11]
    KHAN B, SINGER LG, LILLY LB, et al. Successful lung transplantation from hepatitis C positive donor to seronegative recipient[J]. Am J Transplant, 2017, 17(4):1129-1131. DOI: 10.1111/ajt.14137.
    [12]
    European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2016[J]. J Hepatol, 2017, 66(1):153-194. DOI: 10.1016/j.jhep.2016.09.001.
    [13]
    HÉZODE C. Pan-genotypic treatment regimens for hepatitis C virus: advantages and disadvantages in high-and low-income regions[J]. J Viral Hepat, 2017, 24(2):92-101. DOI: 10.1111/jvh.12635.
    [14]
    POURBAIX A, QUALI N, SOUSSAN P, et al. Evidence of hepatitis E virus transmission by renal graft[J]. Transpl Infect Dis, 2017, 19(1). DOI: 10.1111/tid.12624.
    [15]
    MULLER E, BARDAY Z, MENDELSON M, et al. HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years[J]. N Engl J Med, 2015, 372(7):613-620. DOI: 10.1056/NEJMoa1408896.
    [16]
    CALMY A, VAN DELDEN C, GIOSTRA E, et al. HIV-positive-to-HIV-positive liver transplantation[J]. Am J Transplant, 2016, 16(8):2473-2478. DOI: 10.1111/ajt.13824.
    [17]
    HATHORN E, SMIT E, ELSHARKAWY AM, et al. HIV-positive-to-HIV-positive liver transplantation[J]. N Engl J Med, 2016, 375(18):1807-1809. DOI: 10.1056/NEJMc1603850.
    [18]
    MALANI P. HIV and transplantation: new reasons for HOPE[J]. JAMA, 2016, 316(2):136-138. DOI: 10.1001/jama.2016.8158.
    [19]
    AMBARAGHASSI G, CARDINAL H, CORSILLI D, et al. First Canadian case report of kidney transplantation from an HIV-positive donor to an HIV-positive recipient[J]. Can J Kidney Health Dis, 2017, 4:2054358117695792. DOI: 10.1177/2054358117695792.
    [20]
    GROSSI PA. Risk assessment for HIV+ organ donors: is the CD4 T cell count a marker of increased risk of transmissible diseases?[J]. Transplantation, 2017, 101(4):684-685. DOI: 10.1097/TP.0000000000001626.
    [21]
    COOK LB, MELAMED A, DEMONTIS MA, et al. Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients[J]. Retrovirology, 2016, 13:3. DOI: 10.1186/s12977-015-0236-7.
    [22]
    GUPTA RK, GUPTA G, CHORASIYA VK, et al. Dengue virus transmission from living donor to recipient in liver transplantation: a case report[J]. J Clin Exp Hepatol, 2016, 6(1):59-61. DOI: 10.1016/j.jceh.2016.01.005.
    [23]
    NOGUEIRA ML, ESTOFOLETE CF, TERZIAN AC, et al. Zika virus infection and solid organ transplantation: a new challenge[J]. Am J Transplant, 2017, 17(3):791-795. DOI: 10.1111/ajt.14047.
    [24]
    BARJAS-CASTRO ML, ANGERAMI RN, CUNHA MS, et al. Probable transfusion-transmitted Zika virus in Brazil[J]. Transfusion, 2016, 56(7):1684-1688. DOI: 10.1111/trf.13681.
    [25]
    KAUL DR, MEHTA AK, WOLFE CR, et al. Ebola virus disease: implications for solid organ transplantation[J]. Am J Transplant, 2015, 15(1):5-6. DOI: 10.1111/ajt.13093.
    [26]
    VAN DUIN D, BONOMO RA. Cefazidime/avibactam and cefolozane/tazobactam: second-generation β-lactam/β-lactamase inhibitor combinations[J]. Clin Infect Dis, 2016, 63(2):234-241. DOI: 10.1093/cid/ciw243.
    [27]
    FERNANDEZ R, RATLIFF A, CRABB D, et al. Ureaplasma transmitted from donor lungs is pathogenic after lung transplantation[J]. Ann Thorac Surg, 2017, 103(2):670-671. DOI: 10.1016/j.athoracsur.2016.09.026.
    [28]
    WANG X, GREENWOOD-QUAINTANCE KE, KARAU MJ, et al. Ureaplasma parvum causes hyperammonemia in a pharmacologically immunocompromised murine model[J]. Eur J Clin Microbiol Infect Dis, 2017, 36(3):517-522. DOI: 10.1007/s10096-016-2827-1.
    [29]
    WANG X, KARAU MJ, GREENWOOD-QUAINTANCE KE, et al. Ureaplasma urealyticum causes hyperammonemia in an experimental immunocompromised murine model[J]. PLoS One, 2016, 11(8):e0161214. DOI: 10.1371/journal.pone.0161214.
    [30]
    BHARAT A, CUNNINGHAM SA, SCOTT BUDINGER GR, et al. Disseminated ureaplasma infection as a cause of fatal hyperammonemia in humans[J]. Sci Transl Med, 2015, 7(284):284re3. DOI: 10.1126/scitranslmed.aaa8419.
    [31]
    TROTTER PE, ROBB M, HULME W, et al. Transplantation of organs from deceased donors with meningitis and encephalitis: a UK registry analysis[J]. Transpl Infect Dis, 2016, 18(6):862-871. DOI: 10.1111/tid.12621.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (192) PDF downloads(42) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return